Folotyn is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Acrotech Biopharma Llc. The primary component is Pralatrexate.
Product ID | 72893-003_192ac27b-5caa-4401-a06e-f168d5b8c5b6 |
NDC | 72893-003 |
Product Type | Human Prescription Drug |
Proprietary Name | Folotyn |
Generic Name | Pralatrexate |
Dosage Form | Injection |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2009-09-24 |
Marketing Category | NDA / NDA |
Application Number | NDA022468 |
Labeler Name | Acrotech Biopharma LLC |
Substance Name | PRALATREXATE |
Active Ingredient Strength | 20 mg/mL |
Pharm Classes | Folate Analog Metabolic Inhibitor [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2009-09-24 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022468 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2009-09-24 |
Ingredient | Strength |
---|---|
PRALATREXATE | 20 mg/mL |
SPL SET ID: | 9f3d9c4d-9386-4451-b712-0fbdc5478d8f |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
48818-001 | Folotyn | pralatrexate |
72893-003 | Folotyn | pralatrexate |
72893-005 | Folotyn | pralatrexate |
65219-550 | Pralatrexate | Pralatrexate |
65219-552 | Pralatrexate | Pralatrexate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
FOLOTYN 78881722 3743409 Live/Registered |
Allos Therapeutics, Inc. 2006-05-11 |
FOLOTYN 77939090 3887969 Dead/Cancelled |
Allos Therapeutics, Inc. 2010-02-18 |